Results
1 -
10 of
82Cutaneous Reactions to BRAF Inhibitors, Cutaneous Drug Eruptions B-Raf, Cancer Therapeutic Targets Clinical Utility of BRAF-Targeted Therapy in Melanoma, BRAF Targets in Melanoma Targeted Therapy for Melanoma, Melanoma Update in Immunotherapies for Melanoma, Biologic and Systemic Agents in Dermatology Dabrafenib, Small Molecules in Oncology Simple and cost-effective liquid chromatography-mass spectrometry method to measure dabrafenib quantitatively and six metabolites semi-quantitatively in human plasma, Analytical and Bioanalytical Chemistry Zielgerichtete und immunologische Therapieans??tze beim malignen Melanom, Der Hautarzt Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib, Annals of Hematology